Insulin-dependent diabetes mellitus (IDDM) is a risk factor for periodontitis. Depressed neutrophil chemotaxis has been demonstrated in IDDM and in early-onset periodontitis (EOP). HLA-DR antigens are associated with both IDDM and periodontitis. This investigation sought to determine an association of HLA-DR3, -DR4, and -DR53 with impaired neutrophil chemotaxis in an IDDM sample. The neutrophil chemotaxis index of 41 diabetics and 27 controls was determined by a modified Boyden chamber method, and certain class II HLA genotypes were determined by polymerase chain-reaction amplification of genomic DNA by means of sequence-specific primers (PCR-SSP). The mean chemotaxis index of the diabetics was significantly less than that of the controls (p < 0.02). HLA-DR3 (p ≤ 0.002), -DR4 (p < 0.003), and -DR53 (p < 0.001) were associated with IDDM. Neutrophil chemotaxis and glucose metabolism were not significantly correlated. None of the HLA-DR alleles was associated with impaired neutrophil chemotaxis. Therefore, the neutrophil chemotaxis defect of IDDM appears to be independent of these HLA-DR-associated genes.
Alley CS, Reinhardt RA, Maze CA, DuBois LM, Wahl TO, Duckworth WC, et al. (1993). HLA-D and T lymphocyte reactivity to specific periodontal pathogens in type 1 diabetic periodontitis. J Periodontol64:974-979.
2.
Amer A., Singh G., Darke C., Dolby AE (1988). Association between HLA antigens and periodontal disease. Tissue Antigens31:53-58.
3.
Baum J., Mowat AG, Kirk JA ( 1971). A simplified method for the measurement of chemotaxis of polymorphonuclear leukocytes from human blood. J Lab Clin Med77:501-509.
4.
Cavender DE, Wagener DK, Rabin BS, Becker DJ, Orchard TJ, Eberhardt MS, et al. (1984). The Pittsburgh insulin-dependent diabetes mellitus (IDDM) study. HLA antigens and haplotypes as risk factors for the development of IDDM in IDDM patients and their siblings. J Chronic Dis37:555-568.
5.
Cianciola LJ, Park BH, Bruck E., Mosovich L., Genco RJ (1982). Prevalence of periodontal disease in insulin-dependent diabetes mellitus (juvenile diabetes). J Am Dent Assoc104:653-660.
6.
Cox A., Duff GW ( 1996). Cytokines as genetic modifying factors in immune and inflammatory diseases. J Ped Endocrinol Metabol9:129-132.
7.
Daniel MA, McDonald G., Offenbacher S., Van Dyke TE (1993). Defective chemotaxis and calcium response in localized juvenile periodontitis neutrophils. J Periodontol64:617-621.
8.
Delamater AM, Albrecht DR, Postellon DC, Gutai JP (1991). Racial differences in metabolic control of children and adolescents with type 1 diabetes mellitus. Diabetes Care14:20-25.
9.
dePommereau V., Dargent-Pare C., Robert JJ, Brion M. (1992). Periodontal status in insulin dependent diabetic adolescents. J Clin Periodontol19:628-632.
10.
Deschamps I., Marcelli-Barge A., Poirer JC, Cohen-Haguenauer O., Abderrahim H., Cohen D., et al. (1988). Two distinct HLA-DR3 haplotypes are associated with age related heterogeneity in type 1 (insulin-dependent) diabetes. Diabetologia31:896-901.
11.
Deschamps I., Hors J., Clerget-Darpoux F., Gardais E., Robert JJ, Marcelli-Barge A., et al. (1990). Excess of maternal HLA-DR3 antigens in HLA DR3,4 positive type 1 (insulin-dependent) diabetic patients. Diabetologia33:425-430.
12.
Deschamps I., Boitard C., Hors J., Busson M., Marcelli-Barge A., Mogenet A., et al. (1992). Life table analysis of the risk of type 1 (insulin-dependent) diabetes mellitus in siblings according to islet cell antibodies and HLA markers. A 3-year prospective study. Diabetologia35:951-957.
13.
Firatli E. (1997). The relationship between clinical periodontal status and insulin-dependent diabetes mellitus. Results after 5 years. J Periodontol68:136-140.
14.
Firatli E., Kantarci A., Cebeci I., Tanyeri H., Sonmez G., Carin M., et al. (1996). Association between HLA antigens and early onset periodontitis. J Clin Periodontol23:563-566.
15.
Fletcher J., Mijovic C., Odugbesan O., Jenkins D., Bradwell AR, Barnett AH (1988). Trans-racial studies implicate HLA-DQ as a component of genetic susceptibility to type 1 (insulin-dependent) diabetes. Diabetologia31:864-870.
16.
Gallacher SJ, Thomson G., Fraser WD, Fisher BM, Gemmell CG, MacCuish AC (1995). Neutrophil bactericidal function in diabetes mellitus: Evidence for association with blood glucose control. Diabetic Med12:916-920.
17.
Gervais F., Stevenson M., Skamene E. (1984). Genetic control of resistance to Listeria monocytogenes: Regulation of leukocyte inflammatory responses by the Hc locus. J Immunol132:2078-2083.
18.
Gin H., Brottier E., Aubertin J. (1984). Influence of glycaemic normalisation by an artificial pancreas on phagocytic and bactericidal functions of granulocytes in insulin dependent diabetic patients. J Clin Pathol37:1029-1031.
19.
Hill HR, Sauls HS, Dettloff JL, Quie PG ( 1974). Impaired leukotactic responsiveness in patients with juvenile diabetes mellitus. Clin Immunol Immunopathol2:395-403.
20.
Inoue S., Lan Y., Muran J., Tsuji M. (1996). Reduced hydrogen peroxide production in neutrophils from patients with diabetes. Diabetes Res Clin Pract33:119-127.
21.
Kalmar JR, Arnold RR, Warbington ML, Gardner MK (1988). Superior leukocyte separation with a discontinuous one-step Ficoll-Hypaque gradient for the isolation of human neutrophils. J Immunol Meth110:275-281.
22.
Karjalainen KM, Knuuttila ML (1996). The onset of diabetes and poor metabolic control increases gingival bleeding in children and adolescents with insulin-dependent diabetes mellitus. J Clin Periodontol23:1060-1067.
23.
Karjalainen KM, Knuuttila ML, von Dickhoff KJ (1994). Association of the severity of periodontal disease with organ complications in type 1 diabetic patients. J Periodontol65:1067-1072.
24.
Katz J., Goultschin J., Benoliel R., Brautbar C. (1987). Human leukocyte antigen (HLA) DR4: Positive association with rapidly progressing periodontitis. J Periodontol58:607-610.
25.
Koivuranta-Vaara P., Repo H., Leirisalo M., Kiistala U., Osterman T., Vapaatalo H. (1984). Enhanced neutrophil migration in vivo in HLA-B27 positive subjects. Ann Rheum Dis43:181-185.
26.
Manouchehr-Pour M., Spagnuolo PJ, Rodman HM, Bissada NF (1981). Impaired neutrophil chemotaxis in diabetic patients with severe periodontitis. J Dent Res60:729-730.
27.
Marhoffer W., Stein M., Schleinkofer L., Federlin K. (1993). Evidence of ex vivo and in vitro impaired neutrophil oxidative burst and phagocytic capacity in type 1 diabetes mellitus. Diabetes Res Clin Pract19:183-188.
28.
Marley SB, Hadley CL, Wakelin D. (1994). Effect of genetic variation on induced neutrophilia in mice. Infect Immun62:4304-4309.
29.
McMullen JA, Van Dyke TE, Horoszewicz HU, Genco RJ (1981). Neutrophil chemotaxis in individuals with advanced periodontal disease and a genetic predisposition to diabetes mellitus. J Periodontol52:167-173.
30.
Molenaar DM, Palumbo PJ, Wilson WR, Ritts RE Jr (1976). Leukocyte chemotaxis in diabetic patients and their nondiabetic first-degree relatives. Diabetes25:880-883.
31.
Mowat AG, Baum J. ( 1971). Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. N Engl J Med284:621-627.
32.
Newton CR, Graham A., Heptinstall LE, Powell SJ, Summers C., Kalsheker N., et al. (1989). Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acid Res17:2503-2516.
33.
Offenbacher S. (1996). Periodontal diseases: Pathogenesis. Ann Periodontol1:821-878.
34.
Olerup O., Zetterquist H. (1992). HLA-DR typing by PCR amplification with sequence specific primers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation . Tissue Antigens39:225-235.
35.
Pinson M., Hoffman WH, Garnick JJ, Litaker MS (1995). Periodontal disease and type I diabetes mellitus in children and adolescents. J Clin Periodontol22:118-123.
36.
Rayfield EJ, Ault MJ, Keusch GT, Brothers MJ, Nechemias C., Smith H. (1982). Infection and diabetes: The case for glucose control . Am J Med72:439-450.
37.
Ringelberg ML, Dixon DO, Francis AO, Plummer RW (1977). Comparison of gingival health and gingival crevicular fluid flow in children with and without diabetes. J Dent Res56:108-111.
38.
Salvi GE, Yalda B., Collins JG, Jones BH, Smith FW, Arnold RR, et al. (1997). Inflammatory mediator response as a potential risk marker for periodontal diseases in insulin-dependent diabetes mellitus patients. J Periodontol68:127-135.
39.
Savin JA (1974). Bacterial infections in diabetes mellitus. Br J Dermatol91:481-484.
40.
Schenkein HA, Van Dyke TE (1994). Early-onset periodontitis: Systemic aspects of etiology and pathogenesis. Periodontol20006:7-25.
41.
Schenkein HA, Best AM, Gunsolley JC (1991). Influence of race and periodontal clinical status on neutrophil chemotactic responses. J Periodont Res26:272-275.
42.
Serlenga E., Garofalo AR, DePergola G., Ventura MT, Tortorella C., Antonacci S. (1993). Polymorphonuclear cell-mediated phagocytosis and superoxide anion release in insulin-dependent diabetes mellitus. Cytobios74:189-195.
43.
Shapira L., Eizenberg S., Sela MN, Soskolne A., Brautbar H. (1994). HLA A9 and B15 are associated with the generalized form, but not the localized form, of early-onset periodontal diseases. J Periodontol65:219-223.
44.
Sluiter W., Elzenga-Claasen I., van Hemsbergen-Oomens LW, van der Voort vander Kley-van Andel A., van Dissel JT, van Furth R. (1987). Regulation of granulocyte responses in the blood and peritoneal cavity of CBA and B10 mice during an acute inflammation. J Leukoc Biol42:653-658.
45.
Sznajder N., Carraro JJ, Rugna S., Sereday M. (1978). Periodontal findings in diabetic and nondiabetic patients. J Periodontol49:445-448.
46.
Tater D., Tepaut B., Bercovici JP, Youinou P. (1987). Polymorphonuclear cell derangements in type I diabetes. Horm Metab Res19:642-647.
47.
Van Dyke TE, Horoszewicz HU, Genco RJ (1982). The polymorphonuclear leukocyte (PMNL) locomotor defect in juvenile periodontitis. Study of random migration, chemokinesis and chemotaxis. J Periodontol53:682-687.
48.
Van Dyke TE, Wilson-Burrows C., Offenbacher S., Henson P. (1987). Association of an abnormality of neutrophil chemotaxis in human periodontal disease with a cell surface protein. Infect Immun55:2262-2267.
49.
Wang S., Sun C., Gillanders E., Zhang Y.-J, Lopez N., Schenkein H., Diehl S. (1996). Genome scan for susceptibility loci to the complex disorder early-onset periodontitis (abstract). Am J Hum Genet59:1986.
50.
Wilson AG, di Giovine FS, Duff GW ( 1995). Genetics of tumor necrosis factor alpha in autoimmune, infectious, and neoplastic diseases. J Inflammation45:1-12.
51.
Yalda B., Offenbacher S., Collins JG (1994). Diabetes as a modifier of periodontal disease expression. Periodontol20006:37-49.
52.
Zozulinska DA, Wierusz-Wysocka B., Wysocki H., Majchrzak AE, Wykretowicz A. (1996). The influence of insulin-dependent diabetes mellitus (IDDM) duration on superoxide anion and hydrogen peroxide production by polymorphonuclear neutrophils. Diabetes Res Clin Pract33:139-144.
